Encapsulation of various recombinant mammalian cell types in different alginate microcapsules

Journal of Biomedical Materials Research

Volumn 42, Issue 4, 1998, Pages 587-596

  Peirone, Michael ^a   Ross, Colin J D ^a   Hortelano, Gonzalo ^a,b,c   Brash, John L ^a   Chang, Patricia L ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b Canadian Red Cross Society

^c Canadian Red Cross Society   (Canada)

Author keywords

glucuronidase; Factor IX; Gene therapy; Human growth hormone; Immunoisolation

Indexed keywords

BIOLOGICAL MEMBRANES; CELLS; ENZYMES; GENETIC ENGINEERING; GROWTH KINETICS; HORMONES; IMMUNOLOGY;

GENE THERAPY; HUMAN GROWTH HORMONE; IMMUNOISOLATION; MICROCAPSULES;

ENCAPSULATION;

ALGINIC ACID; BARIUM; BETA GLUCURONIDASE; BLOOD CLOTTING FACTOR 9; CALCIUM; GENE PRODUCT; HUMAN GROWTH HORMONE;

ANIMAL CELL; ARTICLE; BIOMECHANICS; CELL PROLIFERATION; CELL TYPE; DRUG DELIVERY SYSTEM; GENE THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MICROENCAPSULATION; MOUSE; NONHUMAN; SHEAR STRESS;

ALGINATES; ANIMALS; BARIUM; BIOCOMPATIBLE MATERIALS; CALCIUM; CAPSULES; CELL LINE; CELL SURVIVAL; DOGS; EPITHELIAL CELLS; FACTOR X; FIBROBLASTS; GLUCURONIC ACID; GLUCURONIDASE; HEXURONIC ACIDS; HUMAN GROWTH HORMONE; HUMANS; KIDNEY; MAMMALS; POLYLYSINE; RECOMBINANT PROTEINS; STRESS, MECHANICAL; TRANSFECTION;

EID: 0032534528     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(19981215)42:4<587::AID-JBM15>3.0.CO;2-X     Document Type: Article

References (28)

1. T. M. S. Chang, "Artificial cells with emphasis on bioencapsulation," Biotech. Ann. Rev., 1, 267-295 (1995).
2. F. Lim and A. Sun, "Microencapsulated islets as bioartificial endocrine pancreas," Science, 210, 908-910 (1980).
3. J. P. Halle, F. A. Leblond, D. Landry, A. Fournier, and S. Chevalier, "Studies of 300-μm microcapsules. I. Use of arginine esterase release by microencapsulated prostatic cells as a measure of membrane permeability," Transplant. Proc., 24(6), 2930-2932 (1992).
4. P. Soon-Shiong, E. Felderman, R. Nelson, R. Heintz, N. Merideth, P. Sandford, T. Zheng, and J. Komtebedde, "Long-term reversal of diabetes in the large animal model by encapsulated islet transplantation," Transplant. Proc., 24(6), 2946-2947 (1992).
5. P. Soon-Shiong, E. Feldman, R. Nelson, R. Heintz, Q. Yao, Z. Yao, T. Zheng, N. Merideth, G. Skaj-Braek, T. Espevik, O. Smidsrod, and P. Sandford, "Long-term reversal of diabetes by the injection of immunoprotected islets," Proc. Nall, Acad. Sci. USA, 90, 5843-5847 (1993).
6. P. Grohn, G. Klock, J. Schmitt, U. Zimmerman, A. Horcher, R. G. Bretzel, B. J. Hering, H. Brandhorst, T. Zekom, and K. Federlin, "Large-scale production of Ba2+-alginate-coated islets of langerhans for immunoisolation," Exp. Clin. Endocrinol., 102, 380-387 (1994).
7. P. L. Chang, N. Shen, and A. J. Westcott, "Delivery of recombinant gene products with microencapsulated cells in vivo," Hum. Gene Ther., 4, 433-440 (1993).
8. A. Al-Hendy, G. Hortelano, G. S. Tannenbaum, and P. L. Chang, "Allogeneic somatic gene therapy: Correction of growth hormone deficiency in dwarf mice with microencapsulated non-autologous myoblasts," Hum. Gene Ther., 6, 165-175 (1995).
9. H. W. Liu, F. A. Ofosu, and P. L. Chang, "Expression of human factor IX by microencapsulated recombinant fibroblasts," Hum. Gene Ther., 4(3), 291-301 (1993).
10. G. Hortelano, A. Al-Hendy, F. A. Ofosu, and P. L. Chang, "Delivery of human factor IX in mice by microencapsulated recombinant myoblasts: A novel approach towards allogeneic gene therapy of hemophilia B," Blood, 87, 5095-5103 (1996).
11. M. Otterlei, K. Ostgaard, G. Skjak-Braek, O. Smidsrod, P. Soon-Shiong, and T. Espevik, "Induction of cytokine production from human monocytes stimulated with alginate," J. Immunol., 10, 286-291 (1991).
12. A. Martinsen, G. Skjak-Braek, and O. Smidsrod, "Alginate as immobilization material. I. Correlation between chemical and physical properties of alginate gel beads," Biotechnol. Bioeng., 33, 79-89 (1989).
13. M. F. A Goosen, G. M. O'Shea, H. M. Gharapetian, S. Chou, and A. M. Sun, "Optimization of microencapsulation parameters: Semipermeable microcapsules as a bioartificial pancreas," Biotechnol Bioeng., 27, 146-150 (1995).
14. T. Zekorn, U. Siebers, A. Horcher, R. Schnettler, G. Klock, R. G. Bretzel, U. Zimmerman, and K. Federlin, "Barium-alginate for immunoisolated transplantation of islets of langerhans," Transplant. Proc., 24(3), 937-939 (1992).
15. G. Klock, H. Frank, R. Houben, T. Zekorn, A. Horcher, U. Siebers, M. Wohrle, K. Federlin, and U. Zimmerman, "Production of purified alginates suitable for use in immunoisolated transplantation," Appl. Microbiol. Biotechnol., 40,638-643 (1994).
16. J. H. Grubb, J. M. Kyle, L. Cody, and W. S. Sly, "Large scale purification of phosphorylated recombinant human - glucuronidase from overexpressing mouse L cells," FASEB J., 7, A1255 (1993).
17. F. Graham and A. J. Van der Eb, "A new technique for the assay of infectivity of human adenovirus 5 DNA," Virology, 52, 456-467 (1973).
18. P. L. Chang, J. P. Capone, and G. M. Brown, "Autologous fibroblast implantation: Feasibility and potential problems in gene therapy replacement," Mol. Biol. Med., 7, 461-470 (1990).
19. A. M. Sun, "Microencapsulation of pancreatic islet cells: A bioartificial endocrine pancreas," Meth. Enzymol., 137, 575-579 (1988).
20. J. H. Glaser and W. S. Sly, "β-glucuronidase deficiency mucopolysaccharidosis: Methods for enzymatic diagnosis," J. Lab. Clin. Med., 6, 969-977 (1973).
21. G. A. Skarja, D. W. Perry, R. L. Rathbone, F. D. Rubens, and J. L. Brash, "A cone-and-plate device for the investigation of platelet biomaterial interactions," J. Biomed. Mater. Res., 34, 427-438 (1997).
22. P. deVos, G. H. J. Wolters, and R. van Schilfgaarde, "Possible relationship between fibrotic overgrowth of alginate-polylysine-alginate microencapsulated pancreatic islets and the microcapsule integrity," Transplant. Proc., 26(1), 782-783 (1994).
23. H.-J. Park and Y.-H. Khang, "Production of cephalospoiin C by immobilized Cephalosporin acremonium in polyethylene-modified barium alginate," Enzyme Microbiol. Tech., 17, 408-412 (1995).
24. R. P. Lanza, W. M. Kuhtreiber, D. Ecker, J. E. Staruk, and W. L. Chick, "Xenotransplantation of porcine and bovine islets without immunosuppression using uncoated alginate micro-spheres," Transplantation, 59(10), 1377-1384 (1995).
25. D. E. Awrey, M. Tse, G. Hortelano, and P. L. Chang, "Permeability of alginate microcapsules to secretory recombinant gene products," Biotechnol. Bioeng., 52, 472-484 (1996).
26. M. Tse, H. Uludag, M. V. Sefton, and P. L. Chang, "Secretion of recombinant proteins from hydroxyethyl methacrylate-methyl methacrylate capsules," Biotechnol. Bioeng., 51, 271-280 (1996).
27. T. L. Stockly and P. L. Chang, "Nonautologous somatic gene therapy: A novel approach to drug delivery," Drug News and Perspectives, 10, 331-340 (1997).
28. M. A. Peirone, K. Delaney, and P. L. Chang, "Delivery of recombinant human growth hormone to dogs using microencapsulated cells," Hum. Gene Ther., 9, 195-206 (1998).